NO20052909D0 - Tetracyclic 3-substituted indoles having serotonin receptor affinity. - Google Patents

Tetracyclic 3-substituted indoles having serotonin receptor affinity.

Info

Publication number: NO20052909D0
Authority: NO; Norway
Prior art keywords: tetracyclic; serotonin receptor; receptor affinity; substituted indoles; indoles
Prior art date: 2002-12-18

Application number

NO20052909A

Other languages

English (en)

Other versions

NO20052909L (no

NO334030B1 (no

Inventor

Venkata Satya Niro Ramakrishna

Vikas Shreekrishna Shirsath

Rama Sastri Kambhampati

Venkata Satya Veerabhadra Rao

Venkateswarlu Jasti

Original Assignee

Suven Life Sciences Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-18

Filing date

2005-06-15

Publication date

2005-06-15

2005-06-15 Application filed by Suven Life Sciences Ltd filed Critical Suven Life Sciences Ltd

2005-06-15 Publication of NO20052909D0 publication Critical patent/NO20052909D0/no

2005-09-12 Publication of NO20052909L publication Critical patent/NO20052909L/no

2013-11-18 Publication of NO334030B1 publication Critical patent/NO334030B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Physical Education & Sports Medicine (AREA)
Epidemiology (AREA)
Ophthalmology & Optometry (AREA)
Optics & Photonics (AREA)
Rheumatology (AREA)
Physics & Mathematics (AREA)
Psychology (AREA)
Orthopedic Medicine & Surgery (AREA)
Hospice & Palliative Care (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pain & Pain Management (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Anesthesiology (AREA)
Obesity (AREA)
Hematology (AREA)
Child & Adolescent Psychology (AREA)
Otolaryngology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Addiction (AREA)

NO20052909A 2002-12-18 2005-06-15 Tetrasykliske, 3-substituerte indoler samt deres fremstilling og anvendelse NO334030B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IN951MA2002		2002-12-18
PCT/IN2003/000393 WO2004055026A1 (en)	2002-12-18	2003-12-16	Tetracyclic 3-substituted indoles having serotonin receptor affinity

Publications (3)

Publication Number	Publication Date
NO20052909D0 true NO20052909D0 (no)	2005-06-15
NO20052909L NO20052909L (no)	2005-09-12
NO334030B1 NO334030B1 (no)	2013-11-18

Family

ID=40848934

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20052909A NO334030B1 (no)	2002-12-18	2005-06-15	Tetrasykliske, 3-substituerte indoler samt deres fremstilling og anvendelse

Country Status (19)

Country	Link
US (1)	US7781476B2 (no)
EP (1)	EP1581538B1 (no)
JP (1)	JP4571507B2 (no)
KR (1)	KR100739987B1 (no)
CN (1)	CN100378109C (no)
AT (1)	ATE355292T1 (no)
AU (1)	AU2003292510B2 (no)
BR (1)	BRPI0316895C1 (no)
CA (1)	CA2507923C (no)
DE (1)	DE60312226T2 (no)
DK (1)	DK1581538T3 (no)
EA (1)	EA009367B1 (no)
MX (1)	MXPA05005808A (no)
NO (1)	NO334030B1 (no)
NZ (1)	NZ540841A (no)
PT (1)	PT1581538E (no)
SI (1)	SI1581538T1 (no)
WO (1)	WO2004055026A1 (no)
ZA (1)	ZA200504042B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2005005439A1 (en) *	2003-07-09	2005-01-20	Suven Life Sciences Limited	Benzothiazino indoles
PT1704154E (pt)	2004-01-02	2009-08-05	Suven Life Sciences Ltd	Novos indeno[2,1a]indenos e isoindol[2,1-a]indóis
AU2005328870B2 (en)	2005-03-08	2011-02-03	Suven Life Sciences Limited	Process for preparing substituted benzothiazinoindoles
EP1919896B1 (en)	2005-08-12	2009-12-23	Suven Life Sciences Limited	Aminoaryl sulphonamide derivatives as functional 5-ht6 ligands.
WO2007020654A1 (en)	2005-08-16	2007-02-22	Suven Life Sciences	An improved process for the preparation of losartan
EA017007B1 (ru)	2007-01-08	2012-09-28	Сувен Лайф Сайенсиз Лимитед	Соединения 5-(гетероциклил)алкил-n-(арилсульфонил)индола и их применение в качестве лигандов 5-ht
US8003670B2 (en)	2007-05-03	2011-08-23	Suven Life Sciences Limited	Aminoalkoxy aryl sulfonamide compounds and their use as 5-HT6 ligands
WO2008144263A1 (en) *	2007-05-18	2008-11-27	The Ohio State University Research Foundation	Potent indole-3-carbinol-derived antitumor agents
EA017154B1 (ru) *	2007-10-26	2012-10-30	Сувен Лайф Сайенсиз Лимитед	Аминоарилсульфонамидные соединения и их применение в качестве 5-нтлигандов
US8318725B2 (en)	2008-09-17	2012-11-27	Suven Life Sciences Limited	Aryl indolyl sulfonamide compounds and their use as 5-HT6 ligands
WO2010032258A1 (en)	2008-09-17	2010-03-25	Suven Life Sciences Limited	Aryl sulfonamide amine compounds and their use as 5-ht6 ligands
US8153680B2 (en)	2009-08-25	2012-04-10	The Ohio State University Research Foundation	Alkyl indole-3-carbinol-derived antitumor agents
WO2013151982A1 (en)	2012-04-03	2013-10-10	Arena Pharmaceuticals, Inc.	Methods and compounds useful in treating pruritus, and methods for identifying such compounds
IN2013CH05537A (no) *	2013-12-02	2015-06-12	Suven Life Sciences Ltd
KR101938408B1 (ko) *	2014-08-16	2019-01-14	수벤 라이프 사이언시스 리미티드	1-[(2-브로모페닐) 술포닐]-5-메톡시-3-[(4-메틸-1-피페라지닐) 메틸]-1h-인돌 디메실레이트 모노히드레이트의 활성 대사산물 및 상기 활성 대사산물의 디메실레이트 디히드레이트 염
HK1258023A1 (zh) *	2016-05-18	2019-11-01	Suven Life Sciences Limited	纯5-ht6受体拮抗剂与nmda受体拮抗剂的组合
MX381768B (es) *	2016-05-18	2025-03-13	Suven Life Sciences Ltd	Combinación de antagonistas puros del receptor 5-ht6 con inhibidores de la acetilcolinesterasa.
EA036235B1 (ru) *	2016-10-03	2020-10-16	Сувен Лайф Сайенсиз Лимитед	Фармацевтические композиции антагониста 5-ht6
WO2019008484A1 (en) *	2017-07-03	2019-01-10	Suven Life Sciences Limited	NEW USES OF A PURE 5-HT6 RECEPTOR ANTAGONIST

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3489770A (en) *	1967-12-18	1970-01-13	American Home Prod	1-cyclo(lower)alkanoyl or admantanylcarbonyl - 3 - (2-substituted ethyl)indoles
ZA815541B (en) *	1980-08-12	1983-03-30	Glaxo Group Ltd	Heterocyclic compounds
GB8600397D0 (en) *	1986-01-08	1986-02-12	Glaxo Group Ltd	Chemical compounds
GB8719167D0 (en)	1987-08-13	1987-09-23	Glaxo Group Ltd	Chemical compounds
GB8724912D0 (en)	1987-10-23	1987-11-25	Wellcome Found	Indole derivatives
GB8819024D0 (en)	1988-08-10	1988-09-14	Glaxo Group Ltd	Chemical compounds
IL96891A0 (en)	1990-01-17	1992-03-29	Merck Sharp & Dohme	Indole-substituted five-membered heteroaromatic compounds,their preparation and pharmaceutical compositions containing them
CA2042295A1 (fr)	1990-05-15	1991-11-16	Jacques Chauveau	Derives de mediateurs endogenes, leurs sels, procede de preparation, applications, et compositions les renfermant
AU646871B2 (en)	1990-06-07	1994-03-10	Astrazeneca Uk Limited	Therapeutic heterocyclic compounds
CZ283018B6 (cs)	1991-02-01	1997-12-17	Merck Sharp And Dohme Limited	Deriváty imidazolu, triazolu a tetrazolu a farmaceutické přípravky na jejich bázi
GB9113802D0 (en)	1991-06-26	1991-08-14	Smithkline Beecham Plc	Medicaments
GB9210400D0 (en)	1992-05-15	1992-07-01	Merck Sharp & Dohme	Therapeutic agents
KR940007001A (ko) *	1992-09-16	1994-04-26	최승주	새로운 n-신나모일-2-메틸-5-메톡시-3-인돌 아세트산 에스테르, 그 제조방법 및 이를 함유하는 약학적 제제
FR2737220B1 (fr)	1995-07-24	1997-09-26	Adir	Sequences nucleiques codant pour des recepteurs de la melatonine et leurs applications
JP2000026471A (ja) *	1998-07-10	2000-01-25	Nippon Soda Co Ltd	１１−ホルミル−インドロ［１，２−ｂ］［１，２］ベンズイソチアゾールおよび農園芸用殺菌剤
GB9820113D0 (en) *	1998-09-15	1998-11-11	Merck Sharp & Dohme	Therapeutic agents
DK1149078T3 (da) *	1998-12-11	2006-07-10	Univ Virginia Commonwealth	Selektive 5-HT6-receptorligander
US6403808B1 (en) *	1999-12-10	2002-06-11	Virginia Commonwealth University	Selective 5-HT6 receptor ligands
IL130169A (en)	1999-05-27	2006-08-20	Neurim Pharma 1991	Indole derivatives, and pharmaceutical preparations, skin protection preparations, and cosmetics containing them
FR2799757B1 (fr) *	1999-10-15	2001-12-14	Adir	Nouveaux derives polycycliques azaindoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN1317276C (zh) *	2000-09-29	2007-05-23	中国科学院上海药物研究所	一类吲哚基哌啶类化合物及其制备方法和用途
CA2429605A1 (en)	2000-11-20	2002-05-30	Scios Inc.	Indol derivative and their use as inhibitors of p38 kinase
FR2821843B1 (fr) *	2001-03-12	2003-05-09	Servier Lab	Nouveaux derives d'isoindoloindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP2005522432A (ja)	2002-02-05	2005-07-28	グラクソ　グループ　リミテッド	ニューロン成長の促進方法
BR0312176A (pt) *	2002-06-21	2005-04-05	Suven Life Sciences Ltd	Composto, composição farmaceutica, uso de um composto, método para o tratamento, método para reduzir a morbidez e a mortalidade associadas com o excesso de peso, processo para a preparação de um composto, novo intermediario e processo para a preparação de um novo intermediario
ATE444965T1 (de) *	2002-06-21	2009-10-15	Suven Life Sciences Ltd	Sich als therapeutische mittel eignende arylalkylindole mit affinität für den serotoninrezeptor, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten
CN1720227A (zh) *	2002-11-28	2006-01-11	苏文生命科学有限公司	N－芳基磺酰基－3－氨基烷氧基吲哚

2003
- 2003-12-16 CA CA002507923A patent/CA2507923C/en not_active Expired - Fee Related
- 2003-12-16 EA EA200500994A patent/EA009367B1/ru not_active IP Right Cessation
- 2003-12-16 KR KR1020057010266A patent/KR100739987B1/ko not_active Expired - Fee Related
- 2003-12-16 PT PT03768092T patent/PT1581538E/pt unknown
- 2003-12-16 NZ NZ540841A patent/NZ540841A/en not_active IP Right Cessation
- 2003-12-16 DE DE60312226T patent/DE60312226T2/de not_active Expired - Lifetime
- 2003-12-16 EP EP03768092A patent/EP1581538B1/en not_active Expired - Lifetime
- 2003-12-16 SI SI200330795T patent/SI1581538T1/sl unknown
- 2003-12-16 WO PCT/IN2003/000393 patent/WO2004055026A1/en not_active Ceased
- 2003-12-16 MX MXPA05005808A patent/MXPA05005808A/es active IP Right Grant
- 2003-12-16 BR BRPI0316895A patent/BRPI0316895C1/pt not_active IP Right Cessation
- 2003-12-16 JP JP2004560176A patent/JP4571507B2/ja not_active Expired - Fee Related
- 2003-12-16 AT AT03768092T patent/ATE355292T1/de active
- 2003-12-16 AU AU2003292510A patent/AU2003292510B2/en not_active Ceased
- 2003-12-16 US US10/539,262 patent/US7781476B2/en not_active Expired - Fee Related
- 2003-12-16 DK DK03768092T patent/DK1581538T3/da active
- 2003-12-16 CN CNB2003801070251A patent/CN100378109C/zh not_active Expired - Fee Related
2005
- 2005-06-15 NO NO20052909A patent/NO334030B1/no not_active IP Right Cessation
2006
- 2006-01-26 ZA ZA200504042A patent/ZA200504042B/en unknown

Also Published As

Publication number	Publication date
JP2006515843A (ja)	2006-06-08
BRPI0316895C1 (pt)	2021-05-25
EA200500994A1 (ru)	2006-02-24
US7781476B2 (en)	2010-08-24
EP1581538A1 (en)	2005-10-05
ATE355292T1 (de)	2006-03-15
KR100739987B1 (ko)	2007-07-16
CA2507923C (en)	2010-02-02
AU2003292510A1 (en)	2004-07-09
PT1581538E (pt)	2007-05-31
CN1729197A (zh)	2006-02-01
CA2507923A1 (en)	2004-07-01
NO20052909L (no)	2005-09-12
BRPI0316895B8 (pt)	2019-09-03
WO2004055026A8 (en)	2005-06-23
AU2003292510B2 (en)	2009-04-23
JP4571507B2 (ja)	2010-10-27
HK1083840A1 (en)	2006-07-14
ZA200504042B (en)	2006-01-26
BR0316895A (pt)	2005-10-25
SI1581538T1 (sl)	2007-08-31
NZ540841A (en)	2008-08-29
EA009367B1 (ru)	2007-12-28
CN100378109C (zh)	2008-04-02
DE60312226D1 (de)	2007-04-12
DE60312226T2 (de)	2007-11-15
KR20050084185A (ko)	2005-08-26
WO2004055026A1 (en)	2004-07-01
EP1581538B1 (en)	2007-02-28
NO334030B1 (no)	2013-11-18
US20070142398A1 (en)	2007-06-21
BRPI0316895B1 (pt)	2018-07-24
DK1581538T3 (da)	2007-06-25
MXPA05005808A (es)	2005-09-08

Publication	Publication Date	Title
NO20052909D0 (no)	2005-06-15	Tetracyclic 3-substituted indoles having serotonin receptor affinity.
NO20035359D0 (no)	2003-12-02	Nye indolderivater med 5-HT6-reseptoraffinitet
ATE344030T1 (de)	2006-11-15	4-piperazinylbenzolsulfonyl-indole mit 5-ht6 rezeptor-affinität
ATE501118T1 (de)	2011-03-15	Substituierte indole
DE60320439D1 (de)	2008-05-29	Indolderivate als beta-2 agonisten
ATE340792T1 (de)	2006-10-15	Substituierte indole als alpha-1 agonisten
DE60138605D1 (de)	2009-06-18	Phenyl-substituierte indole als h3 histaminrezeptorantagonisten
DK1513832T3 (da)	2014-05-26	Indol, azaindol og relaterede heterocykliske 4-alkenylpiperidinamider
SG146683A1 (en)	2008-10-30	Fused heterocyclic compounds as serotonin receptor modulators
ATE401307T1 (de)	2008-08-15	N-arylsulfonyl-2-substituierte indole mit affinität zum serotonin rezeptor, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
MXPA03003039A (es)	2003-10-15	Derivados de indola y bencimidazola como moduladores del receptor crf.
NO20041604L (no)	2004-06-17	3-substituerte 4-pyrimidonderivater
NO20022803L (no)	2002-06-12	Substituerte indol-mannichbaser
EP1575493A4 (en)	2007-09-12	INDOLE, AZAINDOLE AND PIPERAZINE SULFONYLUREIDO HETEROCYCLIC DERIVATIVES
NO20026168D0 (no)	2002-12-20	3-azabicyklo(3.1.0)heksan derivater med opioid reseptor affinitet
MXPA04000908A (es)	2004-03-26	Compuestos farmaceuticamente activos que tienen estructura de anillo de pirazolotriazolopirimidina triciclica y metodos de uso.
NO20015737L (no)	2002-01-25	Indol derivater
PT1228041E (pt)	2004-02-27	Derivados de indol
PT1068198E (pt)	2003-10-31	Indoles 5-heteroarilo substituidos
IS2431B (is)	2008-10-15	Nýjar indólafleiður
ATE300545T1 (de)	2005-08-15	Substituierte indoline als 5-ht-rezeptor liganden
AU2003281525A1 (en)	2004-02-09	Serotonin receptor
IS8002A (is)	2005-08-29	Setið indólín og indól afleiður
ATE405560T1 (de)	2008-09-15	Indolderivaten
DK1330457T3 (da)	2005-02-28	Cyclopenta[b][1,4]diazepino[6,7,1-hi]indoler som 5HT2C-antagonister

Legal Events

Date	Code	Title	Description
2021-07-26	MM1K	Lapsed by not paying the annual fees